logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.

    • Vitamin B6 Analog class drugs

    FiltersReset Filters
    4 results

    • bonjesta

      (doxylamine succinate and pyridoxine hydrochloride)
      Duchesnay USA, Inc.
      Usage: BONJESTA is indicated for treating nausea and vomiting of pregnancy in women unresponsive to conservative measures. It has not been studied for hyperemesis gravidarum.

    • diclegis

      (doxylamine succinate and pyridoxine hydrochloride)
      Duchesnay USA, Inc.
      Usage: DICLEGIS is indicated for treating nausea and vomiting of pregnancy in women not responding to conservative management. It has not been studied in cases of hyperemesis gravidarum.

    • doxylamine succinate and pyridoxine hydrochloride

      (Doxylamine succinate and pyridoxine hydrochloride)
      Analog Pharma
      Usage: Doxylamine succinate and pyridoxine hydrochloride delayed-release tablets are indicated for the treatment of nausea and vomiting of pregnancy in women unresponsive to conservative management. They have not been studied in cases of hyperemesis gravidarum.

    • doxylamine succinate and pyridoxine hydrochloride

      (Doxylamine succinate and Pyridoxine hydrochloride)
      Bionpharma Inc.,
      Usage: Doxylamine succinate and pyridoxine hydrochloride delayed-release tablets are indicated for treating nausea and vomiting in pregnancy when conservative management fails. They have not been studied in cases of hyperemesis gravidarum.